Healthcare -
Biotechnology - NASDAQ - US
$ 2.475
-8.67 %
$ 176 M
Market Cap
-1.63
P/E
CCCC - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities CCCC - C4 Therapeutics, Inc.
158 M
LAST VALUE
68.41%
2 YEAR CAGR
33.80%
5 YEAR CAGR
0.00%
10 YEAR CAGR